Around 4%-5% of patients with metastatic colorectal cancer present with these biomarkers. The efficacy and safety of the dual immunotherapy were studied in the CheckMate 8HW trial. This phase 3 ...

Bret Hulick was in his second year of medical school at LECOM in Erie, analyzing the case of a 24-year-old colon cancer ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...

Compared with chemotherapy, immune checkpoint inhibitors (ICIs) were associated with improved overall survival in patients with microsatellite instable metastatic colorectal cancer (CRC ...

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in ...

Doctors note an alarming increase in colorectal cancer in adults aged ... Sweeney's cancer was fought with an immunotherapy treatment, radiation and surgery. "I feel lucky to have my late 30s ...

Until now, cell-based immunotherapy has worked mainly on blood ... attributed to her second pregnancy were actually caused by colorectal cancer. Since then, Phelps has been through “pretty ...

A new implant safely triggers potent immune responses against hard-to-treat cancers showing "promise" for pancreatic and ...

Researchers retrospectively analysed data from 368 patients with MSI-H colon cancer across two academic centres. Patients ...

Portuguese researchers have discovered that a type of white blood cell that can identify and kill tumour cells could be the key to a new immunotherapy against colorectal cancer, the most common type ...